New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 4, 2012
16:15 EDTTHRXTheravance initiates Phase 2 study with TD-9855 for treatment of fibromyalgia
announced today initiation of a fibromyalgia Phase 2 study with TD-9855. TD-9855 is an investigational norepinephrine and serotonin reuptake inhibitor for the treatment of central nervous system conditions such as chronic pain and Attention-Deficit/Hyperactivity Disorder.
News For THRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 28, 2014
20:16 EDTTHRXTheravance still doesn't look like a bargain, Barron's says
Theravance shares still don't look like a bargain, even after the stock being down 22% since the end of July, Barron's contends in a follow up article. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use